img

Global Immune Cell Therapy Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immune Cell Therapy Drugs Market Insights, Forecast to 2034

Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient's immune response against diseases like cancer.
Market Analysis and InsightsGlobal Immune Cell Therapy Drugs Market
Global Immune Cell Therapy Drugs market is expected to reach to US$ 3215 million in 2024, with a positive growth of %, compared with US$ 2456 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Immune Cell Therapy Drugs industry is evaluated to reach US$ 17140 million in 2029. The CAGR will be 32.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Immune Cell Therapy Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Immune Cell Therapy Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Aquila BioMedical
BPS Bioscience
Celentyx
Crown Bioscience
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences
Horizon Discovery Group
ImmunXperts
Molecular Imaging
Promega Corporation,Personalis
STC Biologics
Segment by Type
Monoclonal Antibodies
Immunomodulator
Other

Segment by Application


Stomach Cancer
lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Immune Cell Therapy Drugs introduction, etc. Immune Cell Therapy Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Immune Cell Therapy Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Immunomodulator
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Stomach Cancer
1.3.3 lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Drugs Market Perspective (2018-2029)
2.2 Global Immune Cell Therapy Drugs Growth Trends by Region
2.2.1 Immune Cell Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immune Cell Therapy Drugs Historic Market Size by Region (2018-2024)
2.2.3 Immune Cell Therapy Drugs Forecasted Market Size by Region (2024-2029)
2.3 Immune Cell Therapy Drugs Market Dynamics
2.3.1 Immune Cell Therapy Drugs Industry Trends
2.3.2 Immune Cell Therapy Drugs Market Drivers
2.3.3 Immune Cell Therapy Drugs Market Challenges
2.3.4 Immune Cell Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immune Cell Therapy Drugs by Players
3.1.1 Global Immune Cell Therapy Drugs Revenue by Players (2018-2024)
3.1.2 Global Immune Cell Therapy Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immune Cell Therapy Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Immune Cell Therapy Drugs Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Drugs Revenue in 2022
3.5 Global Key Players of Immune Cell Therapy Drugs Head office and Area Served
3.6 Global Key Players of Immune Cell Therapy Drugs, Product and Application
3.7 Global Key Players of Immune Cell Therapy Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Drugs Breakdown Data by Type
4.1 Global Immune Cell Therapy Drugs Historic Market Size by Type (2018-2024)
4.2 Global Immune Cell Therapy Drugs Forecasted Market Size by Type (2024-2029)
5 Immune Cell Therapy Drugs Breakdown Data by Application
5.1 Global Immune Cell Therapy Drugs Historic Market Size by Application (2018-2024)
5.2 Global Immune Cell Therapy Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immune Cell Therapy Drugs Market Size (2018-2029)
6.2 North America Immune Cell Therapy Drugs Market Size by Type
6.2.1 North America Immune Cell Therapy Drugs Market Size by Type (2018-2024)
6.2.2 North America Immune Cell Therapy Drugs Market Size by Type (2024-2029)
6.2.3 North America Immune Cell Therapy Drugs Market Share by Type (2018-2029)
6.3 North America Immune Cell Therapy Drugs Market Size by Application
6.3.1 North America Immune Cell Therapy Drugs Market Size by Application (2018-2024)
6.3.2 North America Immune Cell Therapy Drugs Market Size by Application (2024-2029)
6.3.3 North America Immune Cell Therapy Drugs Market Share by Application (2018-2029)
6.4 North America Immune Cell Therapy Drugs Market Size by Country
6.4.1 North America Immune Cell Therapy Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immune Cell Therapy Drugs Market Size by Country (2018-2024)
6.4.3 North America Immune Cell Therapy Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immune Cell Therapy Drugs Market Size (2018-2029)
7.2 Europe Immune Cell Therapy Drugs Market Size by Type
7.2.1 Europe Immune Cell Therapy Drugs Market Size by Type (2018-2024)
7.2.2 Europe Immune Cell Therapy Drugs Market Size by Type (2024-2029)
7.2.3 Europe Immune Cell Therapy Drugs Market Share by Type (2018-2029)
7.3 Europe Immune Cell Therapy Drugs Market Size by Application
7.3.1 Europe Immune Cell Therapy Drugs Market Size by Application (2018-2024)
7.3.2 Europe Immune Cell Therapy Drugs Market Size by Application (2024-2029)
7.3.3 Europe Immune Cell Therapy Drugs Market Share by Application (2018-2029)
7.4 Europe Immune Cell Therapy Drugs Market Size by Country
7.4.1 Europe Immune Cell Therapy Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immune Cell Therapy Drugs Market Size by Country (2018-2024)
7.4.3 Europe Immune Cell Therapy Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immune Cell Therapy Drugs Market Size (2018-2029)
8.2 China Immune Cell Therapy Drugs Market Size by Type
8.2.1 China Immune Cell Therapy Drugs Market Size by Type (2018-2024)
8.2.2 China Immune Cell Therapy Drugs Market Size by Type (2024-2029)
8.2.3 China Immune Cell Therapy Drugs Market Share by Type (2018-2029)
8.3 China Immune Cell Therapy Drugs Market Size by Application
8.3.1 China Immune Cell Therapy Drugs Market Size by Application (2018-2024)
8.3.2 China Immune Cell Therapy Drugs Market Size by Application (2024-2029)
8.3.3 China Immune Cell Therapy Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Immune Cell Therapy Drugs Market Size (2018-2029)
9.2 Asia Immune Cell Therapy Drugs Market Size by Type
9.2.1 Asia Immune Cell Therapy Drugs Market Size by Type (2018-2024)
9.2.2 Asia Immune Cell Therapy Drugs Market Size by Type (2024-2029)
9.2.3 Asia Immune Cell Therapy Drugs Market Share by Type (2018-2029)
9.3 Asia Immune Cell Therapy Drugs Market Size by Application
9.3.1 Asia Immune Cell Therapy Drugs Market Size by Application (2018-2024)
9.3.2 Asia Immune Cell Therapy Drugs Market Size by Application (2024-2029)
9.3.3 Asia Immune Cell Therapy Drugs Market Share by Application (2018-2029)
9.4 Asia Immune Cell Therapy Drugs Market Size by Region
9.4.1 Asia Immune Cell Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Immune Cell Therapy Drugs Market Size by Region (2018-2024)
9.4.3 Asia Immune Cell Therapy Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Details
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Immune Cell Therapy Drugs Introduction
11.1.4 Aquila BioMedical Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.1.5 Aquila BioMedical Recent Developments
11.2 BPS Bioscience
11.2.1 BPS Bioscience Company Details
11.2.2 BPS Bioscience Business Overview
11.2.3 BPS Bioscience Immune Cell Therapy Drugs Introduction
11.2.4 BPS Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.2.5 BPS Bioscience Recent Developments
11.3 Celentyx
11.3.1 Celentyx Company Details
11.3.2 Celentyx Business Overview
11.3.3 Celentyx Immune Cell Therapy Drugs Introduction
11.3.4 Celentyx Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.3.5 Celentyx Recent Developments
11.4 Crown Bioscience
11.4.1 Crown Bioscience Company Details
11.4.2 Crown Bioscience Business Overview
11.4.3 Crown Bioscience Immune Cell Therapy Drugs Introduction
11.4.4 Crown Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.4.5 Crown Bioscience Recent Developments
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Details
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Introduction
11.5.4 DiscoverX Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.5.5 DiscoverX Corporation Recent Developments
11.6 Explicyte
11.6.1 Explicyte Company Details
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Immune Cell Therapy Drugs Introduction
11.6.4 Explicyte Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.6.5 Explicyte Recent Developments
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Details
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Introduction
11.7.4 Genscript Biotech Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.7.5 Genscript Biotech Corporation Recent Developments
11.8 HD Biosciences
11.8.1 HD Biosciences Company Details
11.8.2 HD Biosciences Business Overview
11.8.3 HD Biosciences Immune Cell Therapy Drugs Introduction
11.8.4 HD Biosciences Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.8.5 HD Biosciences Recent Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Details
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Introduction
11.9.4 Horizon Discovery Group Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.9.5 Horizon Discovery Group Recent Developments
11.10 ImmunXperts
11.10.1 ImmunXperts Company Details
11.10.2 ImmunXperts Business Overview
11.10.3 ImmunXperts Immune Cell Therapy Drugs Introduction
11.10.4 ImmunXperts Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.10.5 ImmunXperts Recent Developments
11.11 Molecular Imaging
11.11.1 Molecular Imaging Company Details
11.11.2 Molecular Imaging Business Overview
11.11.3 Molecular Imaging Immune Cell Therapy Drugs Introduction
11.11.4 Molecular Imaging Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.11.5 Molecular Imaging Recent Developments
11.12 Promega Corporation,Personalis
11.12.1 Promega Corporation,Personalis Company Details
11.12.2 Promega Corporation,Personalis Business Overview
11.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Introduction
11.12.4 Promega Corporation,Personalis Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.12.5 Promega Corporation,Personalis Recent Developments
11.13 STC Biologics
11.13.1 STC Biologics Company Details
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Immune Cell Therapy Drugs Introduction
11.13.4 STC Biologics Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.13.5 STC Biologics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immune Cell Therapy Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immunomodulator
Table 4. Key Players of Other
Table 5. Global Immune Cell Therapy Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Immune Cell Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Immune Cell Therapy Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Immune Cell Therapy Drugs Market Share by Region (2018-2024)
Table 9. Global Immune Cell Therapy Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Immune Cell Therapy Drugs Market Share by Region (2024-2029)
Table 11. Immune Cell Therapy Drugs Market Trends
Table 12. Immune Cell Therapy Drugs Market Drivers
Table 13. Immune Cell Therapy Drugs Market Challenges
Table 14. Immune Cell Therapy Drugs Market Restraints
Table 15. Global Immune Cell Therapy Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Immune Cell Therapy Drugs Revenue Share by Players (2018-2024)
Table 17. Global Top Immune Cell Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2022)
Table 18. Global Immune Cell Therapy Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Immune Cell Therapy Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Immune Cell Therapy Drugs, Headquarters and Area Served
Table 21. Global Key Players of Immune Cell Therapy Drugs, Product and Application
Table 22. Global Key Players of Immune Cell Therapy Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Immune Cell Therapy Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Immune Cell Therapy Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Immune Cell Therapy Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Immune Cell Therapy Drugs Revenue Share by Application (2018-2024)
Table 30. Global Immune Cell Therapy Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Immune Cell Therapy Drugs Revenue Share by Application (2024-2029)
Table 32. North America Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Immune Cell Therapy Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Immune Cell Therapy Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Immune Cell Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Immune Cell Therapy Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Immune Cell Therapy Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Immune Cell Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Immune Cell Therapy Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Immune Cell Therapy Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Immune Cell Therapy Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Immune Cell Therapy Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Immune Cell Therapy Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Immune Cell Therapy Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Immune Cell Therapy Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Aquila BioMedical Company Details
Table 65. Aquila BioMedical Business Overview
Table 66. Aquila BioMedical Immune Cell Therapy Drugs Product
Table 67. Aquila BioMedical Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 68. Aquila BioMedical Recent Developments
Table 69. BPS Bioscience Company Details
Table 70. BPS Bioscience Business Overview
Table 71. BPS Bioscience Immune Cell Therapy Drugs Product
Table 72. BPS Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 73. BPS Bioscience Recent Developments
Table 74. Celentyx Company Details
Table 75. Celentyx Business Overview
Table 76. Celentyx Immune Cell Therapy Drugs Product
Table 77. Celentyx Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 78. Celentyx Recent Developments
Table 79. Crown Bioscience Company Details
Table 80. Crown Bioscience Business Overview
Table 81. Crown Bioscience Immune Cell Therapy Drugs Product
Table 82. Crown Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 83. Crown Bioscience Recent Developments
Table 84. DiscoverX Corporation Company Details
Table 85. DiscoverX Corporation Business Overview
Table 86. DiscoverX Corporation Immune Cell Therapy Drugs Product
Table 87. DiscoverX Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 88. DiscoverX Corporation Recent Developments
Table 89. Explicyte Company Details
Table 90. Explicyte Business Overview
Table 91. Explicyte Immune Cell Therapy Drugs Product
Table 92. Explicyte Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 93. Explicyte Recent Developments
Table 94. Genscript Biotech Corporation Company Details
Table 95. Genscript Biotech Corporation Business Overview
Table 96. Genscript Biotech Corporation Immune Cell Therapy Drugs Product
Table 97. Genscript Biotech Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 98. Genscript Biotech Corporation Recent Developments
Table 99. HD Biosciences Company Details
Table 100. HD Biosciences Business Overview
Table 101. HD Biosciences Immune Cell Therapy Drugs Product
Table 102. HD Biosciences Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 103. HD Biosciences Recent Developments
Table 104. Horizon Discovery Group Company Details
Table 105. Horizon Discovery Group Business Overview
Table 106. Horizon Discovery Group Immune Cell Therapy Drugs Product
Table 107. Horizon Discovery Group Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 108. Horizon Discovery Group Recent Developments
Table 109. ImmunXperts Company Details
Table 110. ImmunXperts Business Overview
Table 111. ImmunXperts Immune Cell Therapy Drugs Product
Table 112. ImmunXperts Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 113. ImmunXperts Recent Developments
Table 114. Molecular Imaging Company Details
Table 115. Molecular Imaging Business Overview
Table 116. Molecular Imaging Immune Cell Therapy Drugs Product
Table 117. Molecular Imaging Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 118. Molecular Imaging Recent Developments
Table 119. Promega Corporation,Personalis Company Details
Table 120. Promega Corporation,Personalis Business Overview
Table 121. Promega Corporation,Personalis Immune Cell Therapy Drugs Product
Table 122. Promega Corporation,Personalis Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 123. Promega Corporation,Personalis Recent Developments
Table 124. STC Biologics Company Details
Table 125. STC Biologics Business Overview
Table 126. STC Biologics Immune Cell Therapy Drugs Product
Table 127. STC Biologics Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 128. STC Biologics Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Cell Therapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Immune Cell Therapy Drugs Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Immunomodulator Features
Figure 5. Other Features
Figure 6. Global Immune Cell Therapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Immune Cell Therapy Drugs Market Share by Application: 2022 VS 2029
Figure 8. Stomach Cancer Case Studies
Figure 9. lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Immune Cell Therapy Drugs Report Years Considered
Figure 15. Global Immune Cell Therapy Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Immune Cell Therapy Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Immune Cell Therapy Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Immune Cell Therapy Drugs Market Share by Players in 2022
Figure 19. Global Top Immune Cell Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Immune Cell Therapy Drugs Revenue in 2022
Figure 21. North America Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Immune Cell Therapy Drugs Market Share by Type (2018-2029)
Figure 23. North America Immune Cell Therapy Drugs Market Share by Application (2018-2029)
Figure 24. North America Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 25. United States Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Immune Cell Therapy Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Immune Cell Therapy Drugs Market Share by Type (2018-2029)
Figure 29. Europe Immune Cell Therapy Drugs Market Share by Application (2018-2029)
Figure 30. Europe Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 31. Germany Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Immune Cell Therapy Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Immune Cell Therapy Drugs Market Share by Type (2018-2029)
Figure 39. China Immune Cell Therapy Drugs Market Share by Application (2018-2029)
Figure 40. Asia Immune Cell Therapy Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Immune Cell Therapy Drugs Market Share by Type (2018-2029)
Figure 42. Asia Immune Cell Therapy Drugs Market Share by Application (2018-2029)
Figure 43. Asia Immune Cell Therapy Drugs Market Share by Region (2018-2029)
Figure 44. Japan Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 54. Brazil Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Aquila BioMedical Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 61. BPS Bioscience Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 62. Celentyx Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 63. Crown Bioscience Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 64. DiscoverX Corporation Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 65. Explicyte Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 66. Genscript Biotech Corporation Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 67. HD Biosciences Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 68. Horizon Discovery Group Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 69. ImmunXperts Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 70. Molecular Imaging Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 71. Promega Corporation,Personalis Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 72. STC Biologics Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries